2006
DOI: 10.1002/cyto.a.20236
|View full text |Cite
|
Sign up to set email alerts
|

Cytomics and drug discovery

Abstract: Pharmaceutical companies try to develop new drugs that have a high success rate of reaching the market. However, current disease models lack a strong correlation to clinical reality, because of the underestimation of the complexity and variability of clinical disease processes. This leads to high attrition rates late in drug development and soaring costs. Improvement of disease models is an important issue to reduce the high attrition rates in drug development. Using cell‐based disease models, which should tak… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
21
0

Year Published

2006
2006
2011
2011

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 14 publications
0
21
0
Order By: Relevance
“…That cytomics is intrinsically connected to drug-development and drug-discovery has been issued by several authors (16,81). Cell death analysis is in the focus of many fields of life sciences from the research on ontogenesis to the drug development.…”
Section: Cell Death Drug Testing and Toxicologymentioning
confidence: 99%
“…That cytomics is intrinsically connected to drug-development and drug-discovery has been issued by several authors (16,81). Cell death analysis is in the focus of many fields of life sciences from the research on ontogenesis to the drug development.…”
Section: Cell Death Drug Testing and Toxicologymentioning
confidence: 99%
“…A plethora of applications are established and routinely used, e.g., for diagnosis and monitoring of immune status [e.g. [1][2][3], toxicology tests [4,5], drug discovery [6][7][8] Journal of BIOPHOTONICS Standardization, calibration, and controls (negative and positive controls) are essential for quality assurance. Cytometers are capable of reliable and repeatable cellular analyses.…”
Section: Introductionmentioning
confidence: 99%
“…LSC was developed by Kamentsky and Kamentsky ('91) in the early 1990's and combines single cell analysis with the ability to analyze solid tissue and cells in culture. A plethora of applications are established and routinely used, including diagnosis and monitoring of immune status (Bocsi et al ., 2006; Brooimans et al ., 2008; Muzzafar et al ., 2009), toxicology tests (Canesi et al ., 2008; Morris et al ., 2009), drug discovery (Van Osta et al ., 2006; Smith et al ., 2007; Krutzik and Crane, 2008), or tumor biology (Gerstner et al ., 2006; Chao et al ., 2008; Balla et al ., 2009; Goodale et al ., 2009). Cytometric analyses allow fast and quantitative examination of thousands to millions of individual cells in heterogeneous populations.…”
Section: Introductionmentioning
confidence: 99%